Discontinuation of antithrombotic management following left atrial appendage occlusion in high bleeding risk patients

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Siu Fung Wong

Royal Sussex County Hospital, Brighton (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail

Impact of left atrial appendage closure on events after severe bleeding in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry

Doctor M. Ruiz Ortiz (Cordoba, ES)

Abstract Slides Video

Presentation thumbnail

Left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter case-control study

Doctor L. De Luca (Milan, IT)

Abstract Slides Video

Presentation thumbnail

An observational analysis of device-related thrombus in patients with atrial fibrillation across different generations of Watchman devices

Doctor K. Pant (New York City, US)

Abstract Slides Video

Presentation thumbnail

Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis

Doctor A. Samaras (Thessaloniki, GR)

Abstract Slides Video

Access the full session

Session thumbnail

Outcomes and strategies in left atrial appendage closure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Session

Outcomes and strategies in left atrial appendage closure

Congress Presentation

What is the optimal anticoagulation/antiplatelet strategy following left atrial appendage closure?

Congress Session

Next frontier in stroke prevention with left atrial appendage closure: the CHAMPION-AF Trial

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources